Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bepanthen Sensiderm
- Development stage
- Unknown
- Lead developer
- Bayer
- Administration
- Topical
01
Overview
Bepanthen Sensiderm is a steroid-free topical emollient and barrier-repair cream developed and marketed by Bayer. It is designed to relieve itching and redness associated with skin barrier damage, such as in atopic dermatitis (eczema), allergic skin reactions, and dry skin. The formulation utilizes a proprietary Lipid Lamellar Technology (LLT) which provides lipids (including ceramides, squalane, and shea butter) in a lamellar structure similar to the skin's own natural intercellular lipids. This allows the cream to integrate into the damaged stratum corneum, restoring the epidermal lipid barrier and reducing transepidermal water loss (TEWL). Additionally, it contains dexpanthenol (provitamin B5), which supports skin hydration and natural regeneration. It is free of fragrances, preservatives, and emulsifiers, making it suitable for sensitive populations including infants and pregnant women.
- Brand names
- Bepanthen Sensiderm
- Other names
- Bepanthen Sensiderm Cream
02
Targets
Stratum corneum intercellular lipid barrier
Beyond the preview
Go deeper on Bepanthen Sensiderm.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bepanthen Sensiderm.